US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Evotec SE

6.21

0.0000

Volume:- -

Turnover:- -

Market Cap:1.10B

PE:-4.91

High:6.21

Open:6.21

Low:6.21

Close:6.21

52wk High:8.58

52wk Low:6.21

Shares:177.30M

Float Shares:128.97M

Volume Ratio:0.44

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2658

EPS(LYR):-1.1450

ROE:-17.98%

ROA:-2.69%

PB:1.17

PE(LYR):-5.42

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Evotec SE

Exchange:

PINK LIMITED

Establishment Date:

1993

Employees:

4788

Office Location:

Essener Bogen 7,Hamburg,Hamburg,Germany

Website:

http://www.evotec.com

Zip Code:

22419

Phone:

Fax:

- -

Introduction:

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals, as well as a strategic partnership with Dewpoint Therapeutics to advance oncology pipeline programs of condensate modifying therapeutics to investigational new drug applications and a licensing agreement with Glycotope GmbH to develop next generation immune cell engaging bispecifics for various potential indications, including solid tumors The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EVOTF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EVOTF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EVOTF\",,,,,undefined,":{"symbol":"EVOTF","market":"US","secType":"STK","nameCN":"Evotec SE","latestPrice":6.21,"timestamp":1771621200000,"preClose":6.21,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":128968469,"shares":177303470,"eps":-1.265813,"marketStatus":"Market Closed","change":0,"latestTime":"02-20 16:00:00 EST Delay","open":6.21,"high":6.21,"low":6.21,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1.265813,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":6.21,"volumeRatio":0.43835730531353434},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EVOTF\",,,,,undefined,":{"symbol":"EVOTF","floatShares":128968469,"roa":"-2.69%","roe":"-17.98%","lyrEps":-1.144984,"volumeRatio":0.43835730531353434,"shares":177303470,"dividePrice":0,"high":6.21,"amplitude":0,"preClose":6.21,"low":6.21,"week52Low":6.21,"pbRate":"1.17","psRate":"1.24","week52High":8.58,"institutionHeld":0,"latestPrice":6.21,"eps":-1.265813,"divideRate":0,"volume":0,"delay":15,"ttmEps":-1.265813,"open":6.21,"prevYearClose":8.01,"prevWeekClose":6.21,"prevMonthClose":6.21,"prevQuarterClose":8.01,"fiveDayClose":6.21,"twentyDayClose":6.21,"sixtyDayClose":8.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EVOTF\",params:#limit:5,,,undefined,":[{"date":"2024-05-22","symbol":"EVOTF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1716364800000,"name":null,"time":"Pre-Market","dateTimestamp":1716350400000,"actualEps":null},{"market":"US","date":"2024-04-24","symbol":"EVOTF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1713931200000,"reportTimeType":"","actualEps":null},{"date":"2022-11-09","symbol":"EVOTF","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1667984400000,"name":null,"time":"","dateTimestamp":1667970000000,"actualEps":null},{"market":"US","date":"2022-08-11","symbol":"EVOTF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1660190400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-05-11","symbol":"EVOTF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1652241600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EVOTF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EVOTF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.4444,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4444,"analysts":9,"updateTime":1770181200000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":531375,"yearFounded":1993,"employeeNum":4788,"address":"Essener Bogen 7,Hamburg,Hamburg,Germany","zipCode":"22419","officePhone":"49 40 560 81 0"},"stockCompanyDetail":{"websiteUrl":"http://www.evotec.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.2178},{"period":"6month","weight":-0.2247},{"period":"1year","weight":-0.1674},{"period":"ytd","weight":-0.0584}],"description":"Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals, as well as a strategic partnership with Dewpoint Therapeutics to advance oncology pipeline programs of condensate modifying therapeutics to investigational new drug applications and a licensing agreement with Glycotope GmbH to develop next generation immune cell engaging bispecifics for various potential indications, including solid tumors The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.","exchange":"PINK LIMITED","name":"Evotec SE","nameEN":"Evotec SE"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"EVOTF\",market:\"US\",,,undefined,":null}}